AntonyDavidLoebelMD

Physician

Dr. Loebel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside HospitalResidency, Psychiatry, 1986 - 1990
University of Washington School of MedicineClass of 1986

PubMed

166 citations
A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan, Justine Kent, Seth C. Hopkins, John H. Krystal, Hailong Cheng
The New England Journal of Medicine. 2020-04-15
44 citations
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study.
Christoph U Correll, Kenneth S Koblan, Seth C Hopkins, Yan Li, Heather Dworak
NPJ Schizophrenia. 2021-12-09
33 citations
Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
Anastasia Georgiades, Vicki G. Davis, Alexandra S. Atkins, Anzalee Khan, Trina W. Walker
Schizophrenia Research. 2017-04-20

Clinical Relevance Versus Statistical Significance: DelBello and Colleagues Respond to EditorialApril 2018
Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017
Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017

Sunovion, Sumitomo Dainippon Pharma and Otsuka Enter Worldwide Development and Commercialization CollaborationSeptember 30th, 2021
Sunovion Pens $890M Otsuka Pact for a Clutch of Neuropsychiatric DrugsSeptember 30th, 2021
NeuroPace Launches Epilepsy Platform to Personalize Seizure CareAugust 4th, 2021
Join now to see all